Mambu

handly is an early stage, VC backed company building an AI first operating system for craft businesses. We recently raised €3.75m from 20VC, Stride and Base10 and are building a small, performant team with high ownership and high trust.

Aira is an AI platform designed for procedural specialties that serves as the payer intelligence layer for medical device companies and surgical practices. The company automates critical back-office workflows while handling the full payer compliance lifecycle, including benefits verification, medical necessity determinations, prior authorization, and appeals management. By functioning as the intelligence layer powering market access teams, Aira helps healthcare providers and device manufacturers navigate the complexity of reimbursement processes to increase patient access to needed procedures. The platform addresses a key pain point in healthcare operations by streamlining the administrative burden that often delays care and complicates market entry for medical innovations.

Aleph is AI-native and designed to be the always-on decision layer for modern businesses, offering real-time data collaboration for finance teams and automating reporting, variance analysis, and forecasting. It operates as a global digital advertising powerhouse serving 150+ countries, connecting over 26,000 advertisers to a 3 billion consumer audience and partnering with major platforms such as TikTok, X, Microsoft, Amazon, Pinterest, Reddit, Spotify and Google. Its mission is to make the digital world accessible to all, while connecting global brands with local audiences in emerging markets and empowering businesses and individuals through its Digital Ad Expert education platform. The company also facilitates cross-border payments and credit underwriting through Local Payments by Aleph, supported by a team of over 1,500 digital experts in 75+ offices and backing from investors including CVC Partners, Mercado Libre, Sony, X (formerly Twitter), and Snap. Aleph serves a spectrum of clients from small startups to multinational corporations, boasting a trial-to-customer conversion rate exceeding 90%.